Journal of Cardiac Failure
Volume 16, Issue 12 , Pages 980-990 , December 2010

Thrombomodulin is Upregulated in Cardiomyocytes During Cardiac Hypertrophy and Prevents the Progression of Contractile Dysfunction

  • Yi-Heng Li, MD, PhD

      Affiliations

    • Department of Internal Medicine, College of Medicine and Hospital, National Cheng Kung University, Tainan, Taiwan
    • Cardiovascular Research Center, College of Medicine and Hospital, National Cheng Kung University, Tainan, Taiwan
    • Corresponding Author InformationReprint requests: Yi-Heng Li, MD, PhD, Department of Internal Medicine, National Cheng Kung University Hospital, 138 Sheng Li Road, Tainan 704, Taiwan. Tel: +886-6-2353535 ext 2392; Fax: +886-6-2753834.
    • ,
  • Hsing-Chun Chung, MS

      Affiliations

    • Department of Internal Medicine, College of Medicine and Hospital, National Cheng Kung University, Tainan, Taiwan
    • Cardiovascular Research Center, College of Medicine and Hospital, National Cheng Kung University, Tainan, Taiwan
    • ,
  • Chawn-Yau Luo, MD

      Affiliations

    • Cardiovascular Research Center, College of Medicine and Hospital, National Cheng Kung University, Tainan, Taiwan
    • Department of Surgery, College of Medicine and Hospital, National Cheng Kung University, Tainan, Taiwan
    • ,
  • Ting-Hsing Chao, MD

      Affiliations

    • Department of Internal Medicine, College of Medicine and Hospital, National Cheng Kung University, Tainan, Taiwan
    • Cardiovascular Research Center, College of Medicine and Hospital, National Cheng Kung University, Tainan, Taiwan
    • ,
  • Kou-Gi Shyu, MD, PhD

      Affiliations

    • Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
    • ,
  • Guey-Yueh Shi, PhD

      Affiliations

    • Cardiovascular Research Center, College of Medicine and Hospital, National Cheng Kung University, Tainan, Taiwan
    • Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    • ,
  • Hua-Lin Wu, PhD

      Affiliations

    • Cardiovascular Research Center, College of Medicine and Hospital, National Cheng Kung University, Tainan, Taiwan
    • Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan

Received 12 February 2010 ,Revised 13 May 2010 ,Accepted 16 June 2010.

References 

  1. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J. 2001;141:334–341
  2. Teiger E, Than VD, Richard L, Wisnewsky C, Tea BS, Gaboury L, et al. Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest. 1996;97:2891–2897
  3. Condorelli G, Morisco C, Stassi G, Notte A, Farina F, Sgaramella G, et al. Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. Circulation. 1999;99:3071–3078
  4. Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem. 1989;264:4743–4746
  5. Tohda G, Oida K, Okada Y, Kosaka S, Okada E, Takahashi S, et al. Expression of thrombomodulin in atherosclerotic lesions and mitogenic activity of recombinant thrombomodulin in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1998;18:1861–1869
  6. Hu J, Higuchi I, Inose M, Niiyama T, Uchida Y, Osame M. Characteristic expression of thrombomodulin in the muscle sarcoplasm in patients with the acute phase of rhabdomyolysis. Eur Neurol. 2000;43:174–180
  7. Suehiro T, Shimada M, Matsumata T, Taketomi A, Yamamoto K, Sugimachi K. Thrombomodulin inhibits intrahepatic spread in human hepatocellular carcinoma. Hepatology. 1995;21:1285–1290
  8. Hanly AM, Redmond M, Winter DC, Brophy S, Deasy JM, Bouchier-Hayes DJ, et al. Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival. Br J Cancer. 2006;94:1320–1325
  9. Ishii H, Majerus PW. Thrombomodulin is present in human plasma and urine. J Clin Invest. 1985;76:2178–2181
  10. Shi CS, Shi GY, Chang YS, Han HS, Kuo CH, Liu C, et al. Evidence of human thrombomodulin domain as a novel angiogenic factor. Circulation. 2005;111:1627–1636
  11. Hamada H, Ishii H, Sakyo K, Horie S, Nishiki K, Kazama M. The epidermal growth factor-like domain of recombinant human thrombomodulin exhibits mitogenic activity for Swiss 3T3 cells. Blood. 1995;86:225–233
  12. Li YH, Hsieh CY, Wang DL, Chung HC, Liu SL, Chao TH, et al. Remodeling of carotid arteries is associated with increased expression of thrombomodulin in a mouse transverse aortic constriction model. Thromb Haemost. 2007;97:658–664
  13. Wang BW, Hung HF, Chang H, Kuan P, Shyu KG. Mechanical stretch enhances the expression of resistin gene in cultured cardiomyocytes via tumor necrosis factor-α. Am J Physiol Heart Circ Physiol. 2007;293:H2305–H2312
  14. Li YH, Liu SL, Shi GY, Tseng GH, Liu PY, Wu HL. Thrombomodulin plays an important role in arterial remodeling and neointima formation in mouse carotid ligation model. Thromb Haemost. 2006;95:128–133
  15. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol. 1976;37:7–11
  16. Ding B, Price RL, Goldsmith EC, Borg TK, Yan X, Douglas PS, et al. Left ventricular hypertrophy in ascending aortic stenosis mice: anoikis and the progression to early failure. Circulation. 2000;101:2854–2862
  17. Hein S, Arnon E, Kostin S, Schönburg M, Elsässer A, Polyakova V, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation. 2003;107:984–991
  18. Ozaki T, Anas C, Maruyama S, Yamamoto T, Yasuda K, Morita Y, et al. Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure. Nephrol Dial Transplant. 2008;23:110–119
  19. Festoff BW, Ameenuddin S, Santacruz K, Morser J, Suo Z, Arnold PM, et al. Neuroprotective effects of recombinant thrombomodulin in controlled contusion spinal cord injury implicates thrombin signaling. J Neurotrauma. 2004;21:907–922
  20. Leri A, Claudio PP, Li Q, Leri A, Claudio PP, Li Q, et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the bcl-2-to-Bax protein ratio in the cell. J Clin Invest. 1998;101:1326–1342
  21. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R, et al. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J. 2000;19:6341–6350
  22. Harris IS, Zhang S, Treskov I, Kovacs A, Weinheimer C, Muslin AJ. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload. Circulation. 2004;110:718–723
  23. Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation. 2000;101:660–667
  24. Mehrhof FB, Müller FU, Bergmann MW, Li P, Wang Y, Schmitz W, et al. In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein. Circulation. 2001;104:2088–2094
  25. Sharfuddin AA, Sandoval RM, Berg DT, McDougal GE, Campos SB, Phillips CL, et al. Soluble thrombomodulin protects ischemic kidneys. J Am Soc Nephrol. 2009;20:524–534
  26. Wolfgang M, Boehme J, Stremmel W. Comparison of three commercially available thrombomodulin ELISA kits. J Immunol Methods. 2004;286:231–240
  27. Sakaguchi G, Tambara K, Sakakibara Y, Ozeki M, Yamamoto M, Premaratne G, et al. Control-released hepatocyte growth factor prevents the progression of heart failure in stroke-prone spontaneously hypertensive rats. Ann Thorac Surg. 2005;79:1627–1634
  28. Friehs I, Barillas R, Vasilyev NV, Roy N, McGowan FX, del Nido PJ. Vascular endothelial growth factor prevents apoptosis and preserves contractile function in hypertrophied infant heart. Circulation. 2006;114(Suppl I):I290–I295
  29. Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien KR, Ross J. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest. 1995;95:619–627
  30. Béchard D, Gentina T, Delehedde M, Scherpereel A, Lyon M, Aumercier M, et al. Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J Biol Chem. 2001;276:48341–48349
  31. Tapon-Bretaudière J, Chabut D, Zierer M, Matou S, Helley D, Bros A, et al. A fucosylated chondroitin sulfate from echinoderm modulates in vitro fibroblast growth factor 2–dependent angiogenesis. Mol Cancer Res. 2002;1:96–102

 This work was supported by grants NSC96-2314-B-006-063-MY2, NSC98-2314-B-006-050-MY2, and NSC 96-2752-B-006-005-PAE from the National Science Council, Taipei, Taiwan and grants NCKUH-9701006 and 9802009 from the National Cheng Kung University Hospital, Tainan, Taiwan.

 See page 989 for disclosure information.

PII: S1071-9164(10)00713-X

doi: 10.1016/j.cardfail.2010.06.415

Journal of Cardiac Failure
Volume 16, Issue 12 , Pages 980-990 , December 2010

Article Tools

* Image Usage & Resolution